Helmut Jeggle
Co-Founder @ Bambusa Therapeutics
Munich, Germany
Helmut Jeggle is a seed investor at Bambusa Therapeutics in Munich focused on Health Care and Drones. Helmut Jeggle is the Co-Founder of Bambusa Therapeutics. He previously worked at ATHOS KG as a General Partner.He is also a founder of Salvia GMBH
- Total investments:
- 9
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Helmut Jeggle invests in
Stages Helmut Jeggle invests in
Countries Helmut Jeggle invests in
Investment Focus
Industry
- Health Care 2 (22%)
- Drones 1 (11%)
- Medical 1 (11%)
- Software 1 (11%)
- Aerospace 1 (11%)
Stage
- Seed 3 (33%)
- Series A 3 (33%)
- Series B 2 (22%)
Country
- Germany 5 (56%)
- United States 1 (11%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Bambusa Therapeutics
|
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | Series A / Nov 17, 2025 | |
|
Bambusa Therapeutics
|
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies. | $15M / Seed / Sep 09, 2024 | |
InPlanet
|
InPlanet helps to remove carbon from the atmosphere in away that is scable, afforable and safe. | $4.5M / Seed / Oct 01, 2023 | |
OQmented
|
OQmented is a spinoff from Fraunhofer Institute for Silicon Technology ISIT in Itzehoe (Germany). The founders of OQmented have been the major drivers in the development of Fraunhofer ISIT's MEMS mirror technology for more than 20 years. Thus, founding OQmented was a consequent next step focussing on commercializing this unique and reliablelaser scanning technology. OQmented develops, integrates and sells complete laser scanning solutions composed of MEMS chip, driver electronics, application specific system electronics and software.OQmented is a one-stop-shop for our customers: Based on a tight cooperation with Fraunhofer ISIT and suppliers the services offered by OQmented to our customers cover the full range from feasibility phase to volume production. | $20M / Series A / Mar 27, 2023 | |
Wingcopter
|
Wingcopter is an award-winning German developer, manufacturer, and operator of unmanned eVTOL fixed-wing aircraft dedicated to improving the lives of people worldwide through meaningful commercial and humanitarian applications. The start-up focuses on the delivery of goods such as medicines to remote health facilities, packages, and food to privatehouseholds. With their unique, patented tilt-rotor mechanism, the electrically powered Wingcopters far exceed the range and payload capabilities of commercial multicopter drones. Taking off and landing vertically like multicopters, Wingcopters fly long distances as efficiently and quickly as fixed-wing aircraft, reaching ranges of up to 75 miles (120 kilometers) and a Guinness world record speed of 150 mph (240 km/h). Even in strong winds of up to 44 mph (71 km/h) or inclement weather, Wingcopters fly autonomously and reliably.Wingcopters are also used for the efficient inspection of public infrastructure and for long-range mapping applications.In 2020, Wingcopter was named a Technology Pioneer by the World Economic Forum. | $44.2M / Series A / Jun 21, 2022 | |
Mimi Hearing Technologies
|
Mimi is the world's leading company for digital hearing tests and sound personalization. The Mimi apps are medical devices in Europe (CE, class 1). With over one million hearing test app downloads from 150 countries, it creates the world’s largest database of digital hearing profiles. With Mimi Defined™, a technology for sound personalizationcould be developed, which - despite the imperfections of human hearing - can optimize the individual hearing experience for everyone. Our software can be integrated into any audio product, from headphones to TVs, smartphones or streaming services. Mimi Hearing Technologies products and integrations have won numerous prestigious international awards, including the CES Innovation Award in Las Vegas (2019 & 2018), the Sonar+D Award for Innovation in Barcelona (2017), the StartUps & Developer Award at the San Francisco Music Tech Summit (2017), the IFA Berlin Prize for Audio Innovation (2017), first place in the Cannes Midem lab competition in the category "Music Discovery" (2016), and the company was a finalist at the Techcrunch Disrupt New York Startup Battlefield in 2014. More information at www.mimi.io | $25M / Series B / Dec 15, 2021 | |
|
OQmented
|
OQmented is a spinoff from Fraunhofer Institute for Silicon Technology ISIT in Itzehoe (Germany). The founders of OQmented have been the major drivers in the development of Fraunhofer ISIT's MEMS mirror technology for more than 20 years. Thus, founding OQmented was a consequent next step focussing on commercializing this unique and reliablelaser scanning technology. OQmented develops, integrates and sells complete laser scanning solutions composed of MEMS chip, driver electronics, application specific system electronics and software.OQmented is a one-stop-shop for our customers: Based on a tight cooperation with Fraunhofer ISIT and suppliers the services offered by OQmented to our customers cover the full range from feasibility phase to volume production. | $9.3M / Seed / Nov 04, 2021 | |
One Data
|
One Data is a software company that offers supply chain optimization and data integration solutions. | $10M / Series B / Sep 29, 2021 | |
|
OQmented
|
OQmented is a spinoff from Fraunhofer Institute for Silicon Technology ISIT in Itzehoe (Germany). The founders of OQmented have been the major drivers in the development of Fraunhofer ISIT's MEMS mirror technology for more than 20 years. Thus, founding OQmented was a consequent next step focussing on commercializing this unique and reliablelaser scanning technology. OQmented develops, integrates and sells complete laser scanning solutions composed of MEMS chip, driver electronics, application specific system electronics and software.OQmented is a one-stop-shop for our customers: Based on a tight cooperation with Fraunhofer ISIT and suppliers the services offered by OQmented to our customers cover the full range from feasibility phase to volume production. | Seed / Mar 11, 2021 |
Co-Investors
About Bambusa Therapeutics
Bambusa Therapeutics operates as biotechnology company, that focuses on developing bispecific antibodies.
Bambusa Therapeutics Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Helmut Jeggle
Co-Founder
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Helmut Jeggle invest in?
Helmut Jeggle invests primarily in Health Care, Drones and Medical startups, most often at Seed and Series A stage. Most of the 9 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Helmut Jeggle last invest?
The most recent investment recorded for Helmut Jeggle closed in Nov 2025. Shizune tracks 9 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
